Hideharu Fukao Selected Research

monosodium(2- (6- hydroxynaphthalen- 2- yl)- 6- methylpyrimidin- 4- yloxy)acetate dihydrate

6/2002

Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hideharu Fukao Research Topics

Disease

3	Thrombosis (Thrombus) 01/2007 - 06/2002
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2004
1	Atherosclerotic Plaque (Atheroma) 09/2004
1	Atherosclerosis 09/2004
1	Carcinoma (Carcinomatosis) 01/2004
1	Melanoma (Melanoma, Malignant) 01/2004
1	Pathologic Neovascularization 07/2002
1	Neurogenic Inflammation 07/2002
1	Carotid Artery Thrombosis 06/2002
1	Venous Thrombosis (Deep-Vein Thrombosis) 06/2002

Drug/Important Bio-Agent (IBA)

2	Thrombin FDA Link 01/2007 - 06/2002
1	PlasminogenIBA 01/2007
1	Apolipoproteins E (ApoE)IBA 09/2004
1	CholesterolIBA 09/2004
1	Evans Blue (Blue, Evans)FDA Link 09/2004
1	HeliumIBA 09/2004
1	LipidsIBA 09/2004
1	Triglycerides (Triacylglycerol)IBA 09/2004
1	ResveratrolIBA 09/2004
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2004
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2004
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2004
1	Plasminogen Activator Inhibitor 1IBA 01/2004
1	AllergensIBA 07/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2002
1	monosodium(2- (6- hydroxynaphthalen- 2- yl)- 6- methylpyrimidin- 4- yloxy)acetate dihydrateIBA 06/2002

Therapy/Procedure

1	Lasers (Laser) 09/2004
1	Oral Administration 06/2002